Alunbrig 90 mg

Alunbrig 90 mg is an oral medication used for targeted therapy in certain cancer treatments. This kit contains 7 tablets of 90 mg and 21 tablets of 180 mg, manufactured by Takeda Canada Inc.

Alunbrig 90 mg is primarily used in the treatment of specific types of cancer. It is designed to target and inhibit certain proteins that contribute to cancer cell growth. Patients often wonder, 'What is Alunbrig used for?' This medication is typically prescribed for advanced or metastatic non-small cell lung cancer with specific genetic markers.

Common effects of Alunbrig 90 mg may include nausea, fatigue, and muscle pain. Some users also report diarrhea and vomiting. These effects can vary widely among individuals, and it's important to consult a healthcare provider for personalized advice.

Alunbrig 90 mg should be handled with care and stored as directed. It is crucial to follow the prescribed dosage and administration instructions. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Alunbrig 90 mg may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of this medication.